PharmaDepth

Company profile

BECTON DICKINSON & CO

NYSE:BDXMedical/Dental Instruments

Drug pipeline (10)

AssetStageRevenueTrialsStatus
CHLORAPREP ONE-STEPapproved—11approved
CHLORAPREP ONE-STEP FREPPapproved—11approved
CHLORAPREP ONE-STEP SEPPapproved—11approved
CHLORAPREP SINGLE SWABSTICKapproved—11approved
CHLORAPREP TRIPLE SWABSTICKapproved—11approved

Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.

Clinical trials (10)

NCT IDPhaseStatusStartCompletionSponsor nameTitle
NCT03224299phase2completed2017-06-212017-08-24Becton, Dickinson and CompanyEffectiveness of an Antimicrobial Agent for Preoperative Skin Preparation
NCT03140254phase2completed2016-09-012017-03-17C. R. BardEvaluating Safety and Effectiveness of Octenidine Dihydrochloride
NCT03229759phase2completed2017-06-212017-08-04Becton, Dickinson and CompanyEvaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth
NCT00553488phase2completed2007-09-012007-12-01Becton, Dickinson and CompanyFeasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
NCT00692484phase3completed2007-10-012008-02-01C. R. BardPilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2 Antiseptics

FDA applications (7)

ApplicationApprovedTypeApplicantProducts
NDA 0215552002-10-07NDABECTON DICKINSON AND CO
NDA 0208322000-07-14NDABECTON DICKINSON AND CO
ANDA 0734162000-03-14ANDABECTON DICKINSON SURGICAL SYSTEM
ANDA 0725251989-10-24ANDABECTON DICKINSON AND CO
NDA 0194761987-01-07NDABECTON DICKINSON AND CO